Safety concerns and risk management of multiple sclerosis therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety concerns and risk management of multiple sclerosis therapies

Published:2016-11-27 Issue:3 Volume:136 Page:168-186
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Soelberg Sorensen P.¹

Affiliation:

1. Department of Neurology; Danish Multiple Sclerosis Center; University of Copenhagen; Rigshospitalet; Copenhagen Denmark

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12712/fullpdf

Reference89 articles.

1. New management algorithms in multiple sclerosis;Sorensen;Curr Opin Neurol,2014

2. Principles of a new treatment algorithm in multiple sclerosis;Hartung;Expert Rev Neurother,2011

3. Gene expression analysis of interferon-{beta} treatment in multiple sclerosis;Sellebjerg;Mult Scler,2008

4. Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study;Calabresi;Lancet Neurol,2014

5. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial;Comi;Lancet Neurol,2012

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Total Side Effects of Oral Agents for the Treatment of Relapsing–Remitting Multiple Sclerosis Patients in Imam Khomeini Clinic in Hamadan;Armaghane Danesh;2024-03-01

2. Mapping the Therapeutic Options for Multiple Sclerosis in Brazil: A Comprehensive Analysis;Sclerosis;2024-02-06

3. Cannabis sativa in Phytotherapy: Reappraisal of Therapeutic Potential and Regulatory Aspects;Current Pharmaceutical Biotechnology;2024-01

4. Tratamiento de la esclerosis múltiple: situación a octubre del 2020 en los hospitales públicos de Costa Rica;Neurología Argentina;2023-12

5. Clinical Research Progress of BTK Inhibitors in the Treatment of Autoimmune Diseases;Current Topics in Medicinal Chemistry;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3